US Stock MarketDetailed Quotes
HOOK HOOKIPA Pharma
- 2.150
- -0.150-6.52%
Close Nov 22 16:00 ET
- 2.110
- -0.040-1.86%
Post 20:01 ET
21.27MMarket Cap-585P/E (TTM)
2.380High2.080Low93.99KVolume2.340Open2.300Pre Close208.40KTurnover1.96%Turnover RatioLossP/E (Static)9.89MShares11.30052wk High0.30P/B10.30MFloat Cap2.08052wk Low--Dividend TTM4.79MShs Float200.000Historical High--Div YieldTTM13.04%Amplitude2.080Historical Low2.217Avg Price1Lot Size
HOOKIPA Pharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -31.51%4.7M | -51.85%1.29M | 1,052.36%36.6M | 41.27%20.13M | -5.38%7.41M | 207.94%6.87M | -2.44%2.68M | 119.79%3.18M | -22.76%14.25M | 100.98%7.83M |
| Operating revenue | -31.51%4.7M | -51.85%1.29M | 1,052.36%36.6M | 41.27%20.13M | -5.38%7.41M | 207.94%6.87M | -2.44%2.68M | 119.79%3.18M | -22.76%14.25M | 100.98%7.83M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -24.44%20.11M | -3.41%21.19M | -6.34%21.99M | 18.09%93.86M | 12.37%21.83M | 25.92%26.62M | 14.15%21.93M | 19.16%23.48M | -12.07%79.49M | -17.03%19.43M |
| Selling and administrative expenses | 37.05%6.73M | -11.25%3.95M | -17.26%4.06M | -0.67%18.63M | 14.38%4.37M | -0.51%4.91M | -11.56%4.45M | -1.41%4.9M | 8.63%18.76M | 8.54%3.82M |
| Research and development costs | -36.79%15.57M | 0.22%19.75M | -3.65%20.17M | 25.90%86.42M | 20.29%21.16M | 34.67%24.63M | 22.04%19.71M | 25.94%20.93M | -17.15%68.65M | -21.53%17.59M |
| Other operating expenses | 25.14%-2.18M | -13.13%-2.51M | 5.10%-2.23M | -41.40%-11.19M | -86.28%-3.71M | -40.12%-2.92M | -13.23%-2.22M | -24.70%-2.35M | 18.59%-7.92M | 21.28%-1.99M |
| Operating profit | 21.99%-15.41M | -3.33%-19.9M | 171.95%14.61M | -13.02%-73.74M | -24.35%-14.42M | -4.45%-19.75M | -16.92%-19.26M | -11.19%-20.3M | 9.33%-65.24M | 40.58%-11.6M |
| Net non-operating interest income expense | -46.81%809K | -11.61%1.07M | 26.69%1.33M | 426.00%4.98M | 48.81%1.19M | 253.72%1.52M | 2,577.55%1.21M | 544.49%1.05M | 208.61%946K | 462.44%801K |
| Non-operating interest income | -48.47%809K | -18.15%1.07M | 13.66%1.33M | 224.13%5.29M | 36.52%1.24M | 193.46%1.57M | 620.33%1.31M | 16,628.57%1.17M | 5,948.15%1.63M | 15,050.00%909K |
| Non-operating interest expense | --0 | --0 | -98.36%2K | -53.86%317K | -54.63%49K | -53.33%49K | -58.01%97K | -49.79%122K | -23.50%687K | -52.42%108K |
| Other net income (expense) | 191.36%761K | -1,188.00%-272K | -606.36%-1.55M | -3,076.79%-12.45M | -789.03%-11.42M | -512.38%-833K | -84.66%25K | -141.67%-220K | 86.21%-392K | 14.05%-1.29M |
| Special income (charges) | ---1.05M | ---54K | ---1.27M | ---12.77M | ---12.77M | --0 | --0 | --0 | --0 | ---- |
| -Less：Restructuring and merger&acquisition | --878K | --54K | --1.27M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Less:Impairment of capital assets | --172K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Write off | ---- | ---- | ---- | --12.77M | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non- operating income (expenses) | 317.41%1.81M | -972.00%-218K | -29.55%-285K | 179.85%313K | 204.44%1.34M | -512.38%-833K | -84.66%25K | -141.67%-220K | 86.21%-392K | 14.05%-1.29M |
| Income before tax | 27.40%-13.84M | -5.99%-19.1M | 173.85%14.38M | -25.55%-81.21M | -104.06%-24.65M | -4.30%-19.07M | -10.16%-18.02M | -8.39%-19.48M | 14.51%-64.69M | 43.10%-12.08M |
| Income tax | 0 | 0 | 0 | 60.00%368K | -28.38%164K | 0 | 0 | 205K | 22,900.00%230K | 229K |
| Net income | 27.40%-13.84M | -5.99%-19.1M | 173.08%14.38M | -25.67%-81.58M | -101.59%-24.82M | -4.30%-19.07M | -10.15%-18.02M | -9.53%-19.68M | 14.21%-64.92M | 42.02%-12.31M |
| Net income continuous Operations | 27.40%-13.84M | -5.99%-19.1M | 173.08%14.38M | -25.67%-81.58M | -101.59%-24.82M | -4.30%-19.07M | -10.15%-18.02M | -9.53%-19.68M | 14.21%-64.92M | 42.02%-12.31M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 27.40%-13.84M | -5.99%-19.1M | 173.08%14.38M | -25.67%-81.58M | -101.59%-24.82M | -4.30%-19.07M | -10.15%-18.02M | -9.53%-19.68M | 14.21%-64.92M | 42.02%-12.31M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 27.40%-13.84M | -5.99%-19.1M | 173.08%14.38M | -25.67%-81.58M | -101.59%-24.82M | -4.30%-19.07M | -10.15%-18.02M | -9.53%-19.68M | 14.21%-64.92M | 42.02%-12.31M |
| Basic earnings per share | 36.42%-1.1 | 30.28%-1.52 | 140.74%1.1 | 13.13%-8.6 | -28.82%-2.19 | 30.80%-1.73 | 5.22%-2.18 | 32.50%-2.7 | 56.96%-9.9 | 73.85%-1.7 |
| Diluted earnings per share | 36.42%-1.1 | 30.28%-1.52 | 140.74%1.1 | 13.13%-8.6 | -28.82%-2.19 | 30.80%-1.73 | 5.22%-2.18 | 32.50%-2.7 | 56.96%-9.9 | 73.85%-1.7 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data